Dr. Georgios Drakakis serves as Professor of Information Technology at the American College of Greece (Deree) since 2018, concurrently holding the position of Chief Executive Officer at Purposeful, an in silico drug repurposing company. He is a Research Area Leader within the Research, Technology & Innovation Network (RTIN) focusing on cheminformatics and bioinformatics. His educational background includes: PhD in Cheminformatics from University of Cambridge (2011-2015) MSc in Advanced Biological Sciences (Bioinformatics) from University of Liverpool (2009-2010) MSc in Computer Science from Trinity College Dublin (2008-2009) BSc in Computer Science from Aristotle University of Thessaloniki (2003-2007) Dr. Drakakis' research centers on applying machine learning and artificial intelligence to drug discovery, repurposing, and computational toxicology. His work bridges cheminformatics, bioinformatics, and data science to develop predictive models for compound mechanism of action, cytotoxicity, and polypharmacological effects. Recent efforts include computational approaches for identifying drug candidates against emerging pathogens like SARS-CoV-2. His publication record features 13 journal articles and 2 book chapters in high-impact venues including ACS Chemical Biology and Journal of Chemical Information and Modeling, with consistent focus on translational computational methods. Notable recognition includes: Engineering and Physical Sciences Research Council Doctoral Prize As an educator, he teaches Machine Vision and Semantic Web for the MSc in Data Science program, and Data Mining for the BSc in Information Technology program. His leadership in RTIN's Cheminformatics & Bioinformatics Research Area demonstrates commitment to advancing computational approaches in pharmaceutical sciences. His dual role as academic and CEO reflects strong industry-academia integration in his career trajectory.